The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy
Open accessAbstract
Ribozyme-directed cleavage of mutant mRNAs appears to be a potentially effective therapeutic measure for dominantly inherited diseases. We previously demonstrated that two ribozymes targeted to the P23H mutation in rhodopsin slow photoreceptor degeneration in transgenic rats for up to 3 months of age when injected before significant degeneration at postnatal day (P) 15. We now have explored whether ribozyme rescue persists at older ages, and whether ribozymes are effective when injected later in the degeneration after significant photoreceptor cell loss. Recombinant adeno-associated virus (rAAV) vectors incorporating a proximal bovine rod opsin promoter were used to transfer either hairpin or hammerhead ribozyme genes to photoreceptors. For the study of long-term survival, rAAV was administered by subretinal injection at P15, and the rats were allowed to live up to 8 months of age. For the study of late-stage gene transfer, rAAV was administered at P30 or P45, when 40–45% of the photoreceptors already had degenerated. Eyes were examined functionally by the electroretinogram and structurally by morphometric analysis. When injected at P15, expression of either ribozyme markedly slowed the rate of photoreceptor degeneration for at least 8 months and resulted in significantly greater electroretinogram amplitudes at least up to P180. When injected at P30 or P45, virtually the same number of photoreceptors survived at P130 as when injected at P15. Ribozyme rescue appears to be a potentially effective, long-term therapy for autosomal dominant retinal degeneration and is highly effective even when the gene transfer is done after significant photoreceptor cell loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Relative tissue-specific expression of two gRNAs for CRISPR/Cas gene editing in myotubes was achieved by linking a muscle-specific MHCK7 promoter (pol II) with gRNA-linked self-cleaving ribozyme sequences derived of Hepatitis delta virus (HDV) and a Hammerhead (HH) sequence [134-137].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [136]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Retinitis pigmentosa. The Friedenwald Lecture.
Berson, E. L. (1993) · PubMed · Cited by 730
Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor
Faktorovich, E. G., Steinberg, R. H., Yasumura, D., Matthes, M. T., & LaVail, M. M. (1990) · Nature · doi:10.1038/347083a0 · Cited by 710
Self-citationLewin, A. S., Drenser, K. A., Hauswirth, W. W., Nishikawa, S., Yasumura, D., Flannery, J. G., & LaVail, M. M. (1998) · Nature Medicine · doi:10.1038/nm0898-967 · Cited by 407
Self-citationEfficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
Flannery, J. G., Zolotukhin, S., Vaquero, M. I., LaVail, M. M., Muzyczka, N., & Hauswirth, W. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6916 · Cited by 407
Self-citationInfluence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat
LaVail, M. M., & Battelle, B.-A. (1975) · Experimental Eye Research · doi:10.1016/0014-4835(75)90080-9 · Cited by 334
Self-citationPhotoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy
Bennett, J., Tanabe, T., Sun, D., Zeng, Y., Kjeldbye, H., Gouras, P., & Maguire, A. M. (1996) · Nature Medicine · doi:10.1038/nm0696-649 · Cited by 316
The Structure, Function and Application of the Hammerhead Ribozyme
Birikh, K. R., Heaton, P. A., & Eckstein, F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-3-00001.x · Cited by 276
Bennett, J., Maguire, A. M., Cideciyan, A. V., Schnell, M., Glover, E., Anand, V., Aleman, T. S., Chirmule, N., Gupta, A. R., Huang, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9920 · Cited by 242
Unoki, K., & LaVail, M. M. (1994) · PubMed · Cited by 238
Self-citationBerson, E. L. (1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080010094039 · Cited by 231
Research works printed but not linked: 10
- E L Berson Invest Ophthalmol Visual Sci 34, 1659–1676 (1993).
- M B Gorin, J C S Breitner, P T V M De Jong, G S Hageman, C C W Klaver, M H Kuehn, J M Seddon Mol Vis 5, 29 (1999).
- D J Zack, M Dean, R S Molday, J Nathans, T M Redmond, E M Stone, A Swaroop, D Valle, B H Weber Mol Vis 5, 30 (1999).
- M Akimoto, S Miyatake, J Kogishi, M Hangai, K Okazaki, J C Takahashi, M Saiki, M Iwaki, Y Honda Invest Ophthalmol Visual Sci 40, 273–279 (1999).
- J J Rossi Ciba Found Symp 209, 195–204 (1997).
- P A Pavco, K S Bouhana, A M Gallegos, A Agrawal, K S Blanchard, S L Grimm, K L Jensen, L E Andrews, F E Wincott, P A Pitot, et al. Clin Cancer Res 6, 2094–2103 (2000).
- K A Drenser, A M Timmers, W W Hauswirth, A S Lewin Invest Ophthalmol Visual Sci 39, 681–689 (1998).
- K Unoki, M M LaVail Invest Ophthalmol Visual Sci 35, 907–915 (1994).
- J J Michon, Z L Li, N Shioura, R J Anderson, M O M Tso Invest Ophthalmol Visual Sci 32, 280–284 (1991).
- J Bennett, D Duan, J F Engelhardt, A M Maguire Invest Ophthalmol Visual Sci 38, 2857–2863 (1997).
Cited by
Hartong, D. T., Berson, E. L., & Dryja, T. P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69740-7 · Cited by 2,924
Diseases Caused by Defects in the Visual Cycle: Retinoids as Potential Therapeutic Agents
Travis, G. H., Golczak, M., Moise, A. R., & Palczewski, K. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105225 · Cited by 419
“Viral-mediated expression of ribozymes that targeted the transgene mRNA reduced expression of the mutant rhodopsin and slowed the rate of photoreceptor degeneration (149, 150).”
BackgroundMechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy
Mendes, H. F., van der Spuy, J., Chapple, J. P., & Cheetham, M. E. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.007 · Cited by 377
Athanasiou, D., Aguila, M., Bellingham, J., Li, W., McCulley, C., Reeves, P. J., & Cheetham, M. E. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.002 · Cited by 373
Bakondi, B., Lv, W., Lu, B., Jones, M. K., Tsai, Y., Kim, K. J., Levy, R., Akhtar, A. A., Breunig, J. J., Svendsen, C. N., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2015.220 · Cited by 296
Metadata
- Authors
- LaVail, M. M., Yasumura, D., Matthes, M. T., Drenser, K. A., Flannery, J. G., Lewin, A. S., & Hauswirth, W. W.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-09-26
- Volume
- 97
- Issue
- 21
- Pages
- 11488-11493
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC17227
- OpenAlex
- W2077508733
- Cited by
- 203
- References
- 38
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 5 · 2015: 8 · 2014: 9 · 2013: 6 · 2012: 12
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- March of Dimes Foundation
- Foundation Fighting Blindness
- Research to Prevent Blindness (EY02162)
- Macula Vision Research Foundation
- National Institutes of Health (EY01919, EY02162)
- National Eye Institute (EY-06842, EY02162, P30EY002162, EY-01919, R01EY011596, R01EY001919, P30EY008571, F32EY006842, R01EY011123, R01EY006842, T32EY007132)
- National Institute of Neurological Disorders and Stroke (P01NS036302)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- retinitis pigmentosa, photoreceptor degeneration, adeno-associated virus vectors, hairpin ribozyme, hammerhead ribozyme, transgenic rats, electroretinogram, long-term survival
- MeSH terms
- Animals, Cell Survival, Photoreceptor Cells, Retinal Diseases, Genetic Therapy, RNA, Catalytic, Animals, Genetically Modified, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy. https://app.cochat.ai/papers/10.1073/pnas.210319397
- The paper
- LaVail, M. M., Yasumura, D., Matthes, M. T., Drenser, K. A., Flannery, J. G., Lewin, A. S., & Hauswirth, W. W. (2000). Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.210319397
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.